| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |